Marrow stromal cells from patients affected by MPS I differentially support haematopoietic progenitor cell development

Journal of Inherited Metabolic Disease

Volumn 28, Issue 6, 2005, Pages 1045-1053

  Baxter, M A ^a   Wynn, R F ^a   Schyma, L ^a   Holmes, D K ^a   Wraith, J E ^a   Fairbairn, L J ^b   Bellantuono, I ^a,c  

^a ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BLOOD DONOR; BONE MARROW CELL; CELL ADHESION; CELL COUNT; CELL CULTURE; CELL DIFFERENTIATION; CELL MATURATION; CELLULAR DISTRIBUTION; CHILD; CLONOGENESIS; COLONY FORMING UNIT GM; CONTROLLED STUDY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HURLER SYNDROME; MICROENVIRONMENT; STROMA CELL; SUPERNATANT;

ADOLESCENT; ANTIGENS, CD34; BONE MARROW; BONE MARROW CELLS; CELL ADHESION; CELL PROLIFERATION; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; COLLAGEN; DERMATAN SULFATE; HEMATOPOIETIC STEM CELLS; HEPARITIN SULFATE; HUMANS; IDURONIDASE; INFANT; MUCOPOLYSACCHARIDOSIS I; STEM CELLS; STROMAL CELLS; TIME FACTORS;

EID: 31644432464     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-005-0136-4     Document Type: Article

References (30)

1. Baxter MA, Wynn RF, Deakin JA, et al (2002) Retrovirally mediated correction of bone marrow-derived mesenchymal stem cells from patients with mucopolysaccharidosis type I. Blood 99: 1857-1859.
2. Bianco P, Gehron Robey P (2000) Marrow stromal stem cells. J Clin Invest 105: 1663-1668.
3. Bruder SP, Jaiswal N, Haynesworth SE (1997) Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 64: 278-294.
4. Calvi LM, Adams GB, Weibrecht KW, et al (2003) Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425: 841-846.
5. Campagnoli C, Bellantuono I, Kumar S, Fairbairn LJ, Roberts I, Fisk NM (2002) High transduction efficiency of circulating first trimester fetal mesenchymal stem cells: Potential targets for in utero ex vivo gene therapy. BJOG 109: 952-954.
6. Campagnoli C, Roberts IA, Kumar S, Bennett PR, Bellantuono I, Fisk NM (2001) Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 98: 2396-2402.
7. Clark BR, Gallagher JT, Dexter TM (1992) Cell adhesion in the stromal regulation of haematopoiesis. Bailliéres Clin Haematol 5: 619-652.
8. Fairbairn LJ, Lashford LS, Spooncer E, et al (1996) Long-term in vitro correction of alpha- L -iduronidase deficiency (Hurler syndrome) in human bone marrow. Proc Natl Acad Sci USA 93: 2025-2030.
9. Gordon MY, Lewis JL, Grand FH, Marley SB, Goldman JM (1996) Phenotype and progeny of primitive adherent human hematopoietic progenitors. Leukemia 10: 1347-1353.
10. Gupta P, Oegema TR Jr, Brazil JJ, Dudek AZ, Slungaard A, Verfaillie CM (2000) Human LTC-IC can be maintained for at least 5 weeks in vitro when interleukin-3 and a single chemokine are combined with O-sulfated heparan sulfates: Requirement for optimal binding interactions of heparan sulfate with early-acting cytokines and matrix proteins. Blood 95: 147-155.
11. Hinek A, Wilson SE (2000) Impaired elastogenesis in Hurler disease: dermatan sulfate accumulation linked to deficiency in elastin-binding protein and elastic fiber assembly. Am J Pathol 156: 925-938.
12. Hobbs JR, Hugh-Jones K, Barrett AJ, et al (1981) Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone-marrow transplantation. Lancet 2: 709-712.
13. Hofling AA, Vogler C, Creer MH, Sands MS (2003) Engraftment of human CD34+ cells leads to widespread distribution of donor-derived cells and correction of tissue pathology in a novel murine xenotransplantation model of lysosomal storage disease. Blood 101: 2054-2063.
14. Hurley RW, McCarthy JB, Verfaillie CM (1995) Direct adhesion to bone marrow stroma via fibronectin receptors inhibits hematopoietic progenitor proliferation. J Clin Invest 96: 511-519.
15. Kodaira Y, Nair SK, Wrenshall LE, Gilboa E, Platt JL (2000) Phenotypic and functional maturation of dendritic cells mediated by heparan sulfate. J Immunol 165: 1599-1604.
16. Na Nakorn T, Traver D, Weissman IL, Akashi K (2002) Myeloerythroid-restricted progenitors are sufficient to confer radioprotection and provide the majority of day 8 CFU-S. J Clin Invest 109: 1579-1585.
17. Nuttall JD, Brumfield LK, Fazzalari NL, Hopwood JJ, Byers S (1999) Histomorphometric analysis of the tibial growth plate in a feline model of mucopolysaccharidosis type VI. Calcif Tissue Int 65: 47-52.
18. Pan C, Nelson MS, Reyes M, et al (2005) Functional abnormalities of heparan sulfate in mucopolysaccharidosis-I are associated with defective biological activity of FGF-2 on human multipotent progenitor cells. Blood 106 (6): 1956-1964.
19. Peters C, Balthazor M, Shapiro EG, et al (1996) Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome. Blood 87: 4894-4902.
20. Peters C, Shapiro EG, Anderson J, et al (1998) Hurler syndrome: II. Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. The Storage Disease Collaborative Study Group. Blood 91: 2601-2608.
21. Pittenger MF, Mackay AM, Beck SC, et al (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
22. Prockop DJ (1997) Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276: 71-74.
23. Ramsay SL, Meikle PJ, Hopwood JJ (2003) Determination of monosaccharides and disaccharides in mucopolysaccharidoses patients by electrospray ionisation mass spectrometry. Mol Genet Metab 78: 193-204.
24. Siczkowski M, Clarke D, Gordon MY (1992) Binding of primitive hematopoietic progenitor cells to marrow stromal cells involves heparan sulfate. Blood 80: 912-919.
25. Termeer CC, Hennies J, Voith U, et al (2000) Oligosaccharides of hyaluronan are potent activators of dendritic cells. J Immunol 165: 1863-1870.
26. Toogood IR, Dexter TM, Allen TD, Suda T, Lajtha LG (1980) The development of a liquid culture system for the growth of human bone marrow. Leuk Res 4: 449-461.
27. Vellodi A, Young EP, Cooper A, et al (1997) Bone marrow transplantation for mucopolysaccharidosis type I: Experience of two British centres. Arch Dis Child 76: 92-99.
28. Verfaillie CM, Benis A, Iida J, McGlave PB, McCarthy JB (1994) Adhesion of committed human hematopoietic progenitors to synthetic peptides from the C-terminal heparin-binding domain of fibronectin: Cooperation between the integrin alpha 4 beta 1 and the CD44 adhesion receptor. Blood 84: 1802-1811.: 1802-1811.
29. Whitley CB, Ramsay NK, Kersey JH, Krivit W (1986) Bone marrow transplantation for Hurler syndrome: Assessment of metabolic correction. Birth Defects Orig Artic Ser 22: 7-24.
30. Zhang J, Niu C, Ye L, et al (2003) Identification of the haematopoietic stem cell niche and control of the niche size. Nature 425: 836-841.